Sunday, June 18, 2023 2:27:39 AM
The comment made was more informative as we grasp for any information. The lack of any real PR to the market when it should be put out like the data not embargoed at ASCO presentation information would have been worthwhile to put on the wires. That would’ve gotten more attention than Les on the BBS.
Dark comedy is a very true statement. I am baffled by some actions over the years. Especially from Woodford when they actually needed a larger partner to not having the Journal ready or lack of PR with TLD. Always painted into a corner. Not the management, the retail shareholders always led to believe of actions to happen having to accept this performance.
I always think they will finally execute and it is always “We are working very hard.” I know the assets are worth more but it has been a very dark comedy.
I am confident of approval and production capability but what a wringer we have been put through.
Dark comedy is a very true statement. I am baffled by some actions over the years. Especially from Woodford when they actually needed a larger partner to not having the Journal ready or lack of PR with TLD. Always painted into a corner. Not the management, the retail shareholders always led to believe of actions to happen having to accept this performance.
I always think they will finally execute and it is always “We are working very hard.” I know the assets are worth more but it has been a very dark comedy.
I am confident of approval and production capability but what a wringer we have been put through.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
